Hyperkalemic blood versus crystalloid cardioplegia in longer clamping times.
The 715 patients who had crystalloid cardioplegia were compared with 5419 who had cold hyperkalemic blood cardioplegia for isolated coronary artery grafting from 1996 through 2001. Creatine kinase-MB was measured preoperatively, at 90 min, and 7 hours after the end of extracorporeal circulation. Correlation of post-bypass creatine kinase-MB release with aortic crossclamp time and other variables in the two cardioplegia groups was made using dichotomous encoding of cardioplegia in a multivariate linear regression model. Creatine kinase-MB levels 90 min after bypass were higher in patients who had crystalloid cardioplegia than in those who had blood cardioplegia. There was a linear relationship between aortic crossclamp time and post-bypass creatine kinase-MB release in both cardioplegia groups. Post-bypass creatine kinase-MB release increased with aortic crossclamp time independently of other factors and significantly more with crystalloid cardioplegia than with blood cardioplegia (the slope of the regression line was 0.230 versus 0.106). Intraaortic balloon pumping was used less frequently in the blood cardioplegia group. There was an advantage with blood cardioplegia for myocardial protection in longer aortic crossclamp times for isolated coronary bypass grafting.
Albert
Alexander A
AA
Clinic for Cardiothoracic Surgery, Heart Institute Lahr/Baden, Germany. alexander.albert@heart-lahr.com
Arnrich
Bert
B
Walter
Jörg A
JA
Hassanein
Wael M
WM
Rosendahl
Ulrich P
UP
Gehle
Petra
P
Schön
Frank
F
Ennker
Jürgen
J
D015415:Biomarkers / Q000097:blood; D001026:Coronary Artery Bypass / Q000295:instrumentation; D003327:Coronary Disease / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D003402:Creatine Kinase / Q000187:drug effects / Q000378:metabolism; D052279:Creatine Kinase, MB Form; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007423:Intra-Aortic Balloon Pumping; D007527:Isoenzymes / Q000187:drug effects / Q000378:metabolism; D015999:Multivariate Analysis; D017680:Potassium Compounds / Q000097:blood* / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D013223:Statistics as Topic; D013318:Stroke Volume / Q000502:physiology; D013525:Surgical Instruments; D013997:Time Factors; D016896:Treatment Outcome
D015415:Biomarkers; D007527:Isoenzymes; D017680:Potassium Compounds; C018369:potassium cardioplegic solution; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form